Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug…
In a groundbreaking meta-analysis conducted by the Centro Nacional de Investigaciones Cardiovasculares (CNIC) alongside an international consortium of researchers, long-standing…